As of 2025-03-17, the Relative Valuation of Dechra Pharmaceuticals PLC (DPH.L) is (417.22) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 3,866.00 GBP, the upside of Dechra Pharmaceuticals PLC based on Relative Valuation is -110.8%.
The range of the Relative Valuation is (381.81) - (491.60) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.6x - 20.1x | 17.0x |
| Forward P/E multiples | 15.6x - 20.1x | 17.0x |
| Fair Price | (381.81) - (491.60) | (417.22) |
| Upside | -109.9% - -112.7% | -110.8% |
| Date | P/E |